# Allergan Sales, LLC – FDA Inspection, Feb 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/allergan-sales-llc/33a55514-c574-4083-ae1f-d8050a78d708
Source feed: FDA_Inspections

> FDA inspection 1080772 of Allergan Sales, LLC, February 27, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1080772
- Company Name: Allergan Sales, LLC
- Inspection Date: 2019-02-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1316492 - 2026-07-31](https://www.keypedia.com/records/fda_inspections/allergan-sales-llc/78d79be5-3839-460d-a935-35014e5d0753)
- FDA Inspection 1166865 - 2022-03-24
- [FDA Inspection 991999 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/allergan-sales-llc/aef1ef79-fb27-4c50-8fe2-54efc8517774)
- FDA Inspection 947137 - 2015-10-08
- FDA Inspection 937479 - 2015-07-10

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/stephen-d-brown/01ff1439-f6d7-4501-a104-573dae30d306)

Company: https://www.keypedia.com/companies/allergan-sales-llc/dced41da-32c6-41b1-829c-6287550c2c71

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c